St. Jude Medical, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 125   

Articles published

STJ 62.30 -0.64 (-1.02%)
price chart
June 21st Options Now Available For St. Jude Medical (STJ)
Investors in St. Jude Medical, Inc. (NYSE: STJ) saw new options begin trading today, for the June 21st expiration.
Heart Device Lawsuits Continue Against St. Jude Medical, Inc. Over Defective ...
LOS ANGELES, April 18, 2014 /PRNewswire/ -- The Torkzadeh Law Firm (TorkLaw) is now representing over 100 clients against St. Jude Medical, Inc. related to the recalled St. Jude Medical, Inc. Riata leads. In November 2011, the FDA issued a Class 1 ...
St. Jude Medical Announces First Quarter 2014 Earnings Conference Call
ST. PAUL, Minn., Apr 02, 2014 (BUSINESS WIRE) -- St. Jude Medical, Inc. (NYSE:STJ) , a global medical device company, will issue a news release announcing its first quarter 2014 results on Wednesday, April 16, 2014 at approximately 6:30 a.m.
Related articles »  
St. Jude Medical Inc. (STJ) Weakened On Outlook
St. Jude Medical Inc. (STJ: Quote) reported first quarter adjusted EPS of $0.96 Wednesday morning, up from $0.92 in the previous year.
St. Jude Medical 1st-quarter profit rises  MiamiHerald.com
Related articles »  
Spine stimulator from St. Jude Medical Inc. receives FDA approval
FDA recently approved St. Jude Medical's Prot�g� spine stimulator for the treatment of chronic pain. The company describes the device as the first neurostimulation system equipped for upgrades without surgery.
FDA OK for spinal cord stimulation system  Today's Medical Developments
Related articles »  
St. Jude Medical earnings rise 12%
St. Jude Medical Inc. said its first-quarter earnings rose 12% as the medical device maker reported modest sales growth at its core heart-rhythm device business.
St. Jude Medical Rating Reiterated by Canaccord Genuity (STJ)
St. Jude Medical, Inc. logo St. Jude Medical (NYSE:STJ)'s stock had its �sell� rating reaffirmed by analysts at Canaccord Genuity in a research report issued to clients and investors on Thursday, Analyst Ratings Net reports.
St. Jude Medical's �Sell� Rating Reaffirmed at Citigroup Inc. (STJ)
St. Jude Medical, Inc. logo Citigroup Inc. reissued their sell rating on shares of St. Jude Medical (NYSE:STJ) in a research report sent to investors on Monday morning, American Banking News reports.
St. Jude Medical Receives Average Rating of "Hold" from Analysts ...  Watch List News (press release)
Related articles »  
St. Jude Medical, Inc. (STJ) Prot�g� IPG Approved by US FDA
St. Jude Medical, Inc. (NYSE: STJ) announced the approval of its Prot�g� IPG from the U.S. Food and Drug Administration (FDA).
World's First and Only Upgradeable Spinal Cord Stimulation System ...  Wall Street Journal
Related articles »  
St. Jude Medical, Inc. (NYSE:STJ) � Technical Analysis
Dallas, Texas 04/21/2014 (FINANCIALSTRENDS) - St. Jude Medical, Inc. (NYSE:STJ) on the daily chart has been in a downtrend right from the time it hit the intra-day high of $68.51 in the beginning of March 2014.